On the earnings call in August, new CEO Katie Szyman, who joined Masimo in February from BD, sought to reassure investors that the company’s decades-long relationship with Philips remained strong.

No seven-year itch here: After spending the better part of a decade putting aside their differences to team up on the combination of their respective patient monitoring technologies, Philips and ...

Philips and Masimo have renewed their partnership to expedite the development and delivery of next-generation patient monitoring solutions. This multi-year strategic collaboration seeks to broaden the ...

At the heart of the expanded partnership is a joint effort to integrate Masimo’s advanced monitoring technologies – including SET® pulse oximetry, Radius PPG, and a range of sensor technology – into ...

As part of the company’s focus on the development of advanced monitoring solutions, Royal Philips (NYSE: PHG; AEX: PHIA) today announced the launch of its IntelliVue patient monitoring platform with ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Masimo and Philips renewed a multi-year strategic ...

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Masimo (NASDAQ: MASI) today announced that the two companies have renewed their multi-year ...